Healthcare Global Enterprises Limited

Healthcare Global Enterprises Limited (HCG) is a small-cap Healthcare company valued at ₹8,779 crore operating in Hospital on the NSE and BSE.

Recent price move

Healthcare Global Enterprises Limited last traded at ₹583.9, modestly down 1.13% on the day.

Recent developments

On 2026-06-30, the company reported a net profit of ₹16 crore for the latest quarter, up from ₹6 crore in the same quarter a year earlier. Domestic institutional holding increased by 0.29 percentage points to 19.20% as of 2026-06-30.

Financial performance

The company's revenue grew 14.8% annually, but net profit fell 53.5% year-on-year. The latest quarter saw revenue rise 13.4% compared to the same quarter a year earlier, while net profit surged 174.3%, indicating improved profitability in the recent period.

Valuation multiples

The stock trades at 602.0 times earnings, a premium to the Healthcare median of 32.0, 7.90 times book value.

Things to watch

The net profit margin narrowed to 0.9% from 2.2% in the prior year. The company has not paid dividends despite reporting profits. Promoter shares pledged account for 5.17% of promoter holding, which may indicate liquidity concerns.

Where it stands

The company's revenue has grown steadily over the past five years at a 20.3% CAGR, but net profit has declined significantly year-on-year. The latest quarter showed a sharp rise in net profit, which is the most recent key figure. The company's return on equity remains low at 1.0%, and it has not distributed any dividends to shareholders.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.